As the individual loss of either BRG1 or BRM is highly tumorigenic, we hypothesized that the loss of both BRG1 and BRM completely inactivates SWI/SNF-dependent pathways, which causes cancer development. The gene discussed is SMARCA4; the disease is cancer.